Holocene Advisors’s Globus Medical GMED Stock Holding History

Holocene Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.7M	Buy	+773,834	New	+$69.5M	0.16%	154
2025 Q2	–	Sell	-460,087	Closed	-$33.7M	–	804
2025 Q1	$33.7M	Buy	+460,087	New	+$38M	0.1%	195
2024 Q1	–	Sell	-137,193	Closed	-$7.31M	–	772
2023 Q4	$7.31M	Buy	137,193 +53,637	+64%	+$2.61M	0.03%	305
2023 Q3	$4.15M	Sell	83,556 -47,901	-36%	-$2.68M	0.02%	423
2023 Q2	$7.83M	Buy	131,457 +115,590	+728%	+$6.59M	0.03%	299
2023 Q1	$899K	Buy	+15,867	New	+$1.02M	﹤0.01%	598
2021 Q2	–	Sell	-10,691	Closed	-$659K	–	874
2021 Q1	$659K	Buy	10,691 +2,945	+38%	+$187K	﹤0.01%	730
2020 Q4	$505K	Buy	+7,746	New	+$445K	﹤0.01%	639
2020 Q1	–	Sell	-32,659	Closed	-$1.92M	–	727
2019 Q4	$1.92M	Buy	32,659 +15,006	+85%	+$815K	0.02%	411
2019 Q3	$902K	Buy	+17,653	New	+$841K	0.01%	510
2019 Q2	–	Sell	-5,433	Closed	-$268K	–	682
2019 Q1	$268K	Buy	+5,433	New	+$246K	﹤0.01%	567
2018 Q4	–	Sell	-7,659	Closed	-$435K	–	714
2018 Q3	$435K	Buy	+7,659	New	+$403K	0.01%	577

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Holocene Advisors's GMED Position: Q1 2026 in Review

Holocene Advisors opened a new position in Globus Medical (GMED) in Q1 2026: 773,834 shares worth $66.7M. The stake represents 0.16% of the portfolio and ranks #154 among its holdings. This is a return to the name: Holocene Advisors previously reported a position in GMED as recently as Q1 2025.

Holocene Advisors first reported a position in GMED in Q3 2018 and has held it in 12 quarters since. 603 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Holocene Advisors held 773,834 shares of Globus Medical worth $66.7M as of Q1 2026.
Globus Medical was a new Holocene Advisors position in Q1 2026.
Globus Medical made up 0.16% of Holocene Advisors's portfolio in Q1 2026, its #154 holding.
Holocene Advisors first reported a position in Globus Medical in Q3 2018 and has held it in 12 quarters since.
603 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.